Information  X 
Enter a valid email address
  Print          More announcements

Thursday 15 April, 2021

JP Morgan Sec LLC

AON PLC 8.3 AMEND

RNS Number : 6293V
J.P. Morgan Securities LLC
15 April 2021
 

 Ap19

 

 

  AMENDMENT

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

AON plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.01 ordinary shares

Date of dealing

 22 March 2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

6,907,741  3.05

2,124,595  0.94

(2) Derivatives (other than options)

1,843,154  0.81

32,644  0.01

(3)Optionsandagreementstopurchase/sell



Total

8,750,895  3.86

2,157,239  0.95

 


Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

  Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (USD)

 

  (Note 5)

Purchase (New Borrow)

 

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

 

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

3,600

 

9

 187

 27

 200

 51

 101

 25

 12

 2,528

 28

 27

 1

 220

 354

 2,035

 557

 5,591

 3

 1

 82

 100

 1,317

 147

 11,900

 616

 800

 2

 7

 300

 438

 37

 300

 8

 4,600

 24

 2

 100

 2

 20

 1,400

 7

 203

 25

 77

 1

 2

 300

 25

 20

 3,094

 

 5

 34

 1

 5

 51

 109

 2,528

 27

 1

 220

 557

 111

 6,662

 3

 1

 1

 9

 100

 11,900

 438

 3

 15

 28

 15

 1

 1,547

N/A

 

222.1800  USD

222.3809  USD

222.5648  USD

222.6250  USD

222.6400  USD

222.7870  USD

222.8020  USD

222.8300  USD

222.9000  USD

222.9107  USD

222.9200  USD

223.0000  USD

223.0335  USD

223.1691  USD

223.2613  USD

223.3161  USD

223.4000  USD

223.4675  USD

223.4900  USD

223.4970  USD

223.5300  USD

223.5485  USD

223.5500  USD

223.5555  USD

223.5575  USD

223.5588  USD

223.5700  USD

223.5743  USD

223.5800  USD

223.5873  USD

223.5949  USD

223.5967  USD

223.5975  USD

223.6243  USD

223.6288  USD

223.6300  USD

223.6500  USD

223.6550  USD

223.6720  USD

223.7250  USD

223.7300  USD

223.7400  USD

223.8258  USD

223.8616  USD

223.9100  USD

223.9200  USD

223.9567  USD

224.2300  USD

224.5400  USD

223.4487  USD

 

222.1800  USD

222.2150  USD

222.5300  USD

222.5440  USD

222.6400  USD

222.6724  USD

222.9000  USD

222.9600  USD

223.0000  USD

223.0335  USD

223.3161  USD

223.3890  USD

223.4000  USD

223.4600  USD

223.4900  USD

223.5000  USD

223.5150  USD

223.5481  USD

223.5555  USD

223.5873  USD

223.6400  USD

223.7000  USD

223.7689  USD

223.8600  USD

223.9100  USD

223.4487  USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD)

(Note 5)

Equity Swap

Decrease Long

 

 

 

 

Increase Long

 

Increase Short

11

 11,900

 267

 160

 

 220

 

 557

223.4555  USD

223.5555  USD

223.5817  USD

223.5898  USD

 

223.0335  USD

 

223.3161  USD

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price (USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)








 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)




 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)




 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

  None

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    No

 

Dateofdisclosure

 15 April 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEFLFFFSTIELIL

a d v e r t i s e m e n t